Total Payments
$27,870
2024 Payments
$1,660
Companies
58
Transactions
615
Medicare Patients
1,883
Medicare Billing
$206,637
Payment Breakdown by Category
Food & Beverage$12,595 (45.2%)
Other$7,273 (26.1%)
Travel$4,497 (16.1%)
Research$1,823 (6.5%)
Consulting$1,575 (5.7%)
Education$107.27 (0.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $12,595 | 569 | 45.2% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $7,273 | 6 | 26.1% |
| Travel and Lodging | $4,497 | 20 | 16.1% |
| Unspecified | $1,823 | 17 | 6.5% |
| Consulting Fee | $1,575 | 2 | 5.7% |
| Education | $107.27 | 1 | 0.4% |
Payments by Type
General
$26,047
598 transactions
Research
$1,823
17 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| US WorldMeds, LLC | $7,554 | 22 | $0 (2020) |
| Medtronic USA, Inc. | $2,578 | 18 | $0 (2018) |
| ACADIA Pharmaceuticals Inc | $2,373 | 36 | $0 (2024) |
| Abbott Laboratories | $2,302 | 30 | $0 (2021) |
| Neurocrine Biosciences, Inc. | $2,227 | 29 | $0 (2024) |
| Boston Scientific Corporation | $1,580 | 12 | $0 (2024) |
| ABBVIE INC. | $1,533 | 73 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $1,141 | 60 | $0 (2024) |
| Allergan, Inc. | $832.63 | 50 | $0 (2021) |
| MDD US Operations, LLC | $702.42 | 16 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,660 | 66 | ABBVIE INC. ($514.47) |
| 2023 | $1,841 | 83 | ABBVIE INC. ($476.59) |
| 2022 | $3,401 | 100 | Neurocrine Biosciences, Inc. ($1,745) |
| 2021 | $1,632 | 62 | MDD US Operations, LLC ($500.00) |
| 2020 | $3,019 | 74 | ACADIA Pharmaceuticals Inc ($1,823) |
| 2019 | $10,144 | 103 | US WorldMeds, LLC ($7,439) |
| 2018 | $3,767 | 70 | Medtronic USA, Inc. ($2,559) |
| 2017 | $2,407 | 57 | Abbott Laboratories ($1,378) |
All Payment Transactions
615 individual payment records from CMS Open Payments — Page 1 of 25
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $20.01 | General |
| Category: Rare Disease | ||||||
| 12/19/2024 | ABBVIE INC. | VYALEV (Drug) | Food and Beverage | In-kind items and services | $12.26 | General |
| Category: NEUROSCIENCE | ||||||
| 12/17/2024 | Averitas Pharma Inc. | QUTENZA (Drug) | Food and Beverage | In-kind items and services | $27.24 | General |
| Category: PAIN MANAGEMENT | ||||||
| 12/04/2024 | ABBVIE INC. | VYALEV (Drug) | Food and Beverage | In-kind items and services | $20.51 | General |
| Category: NEUROSCIENCE | ||||||
| 11/07/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $19.40 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 11/04/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $28.11 | General |
| Category: Neurology | ||||||
| 10/29/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $32.43 | General |
| Category: NEUROLOGY | ||||||
| 10/18/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $27.12 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/17/2024 | Lilly USA, LLC | AMYVID (Drug), KISUNLA | Food and Beverage | In-kind items and services | $15.75 | General |
| Category: Neuroscience | ||||||
| 10/10/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $23.28 | General |
| Category: Rare Disease | ||||||
| 09/29/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $165.54 | General |
| Category: General - DBS_NMD | ||||||
| 09/24/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $15.99 | General |
| Category: Central Nervous System | ||||||
| 09/19/2024 | AstraZeneca Pharmaceuticals LP | WAINUA (Drug) | Food and Beverage | In-kind items and services | $20.84 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/19/2024 | ABBVIE INC. | DUOPA (Drug) | Food and Beverage | In-kind items and services | $10.13 | General |
| Category: NEUROSCIENCE | ||||||
| 09/11/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $20.94 | General |
| Category: Neuropsychiatry | ||||||
| 09/05/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $20.92 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 09/04/2024 | REVANCE THERAPEUTICS, INC. | DAXXIFY (Drug) | Food and Beverage | In-kind items and services | $23.95 | General |
| Category: AESTHETICS AND THERAPEUTICS | ||||||
| 09/03/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $20.98 | General |
| Category: Central Nervous System | ||||||
| 08/30/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $23.78 | General |
| Category: Neuropsychiatry | ||||||
| 08/27/2024 | ABBVIE INC. | BOTOX (Biological), QULIPTA | Food and Beverage | In-kind items and services | $24.95 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 08/26/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $26.01 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 08/23/2024 | ABBVIE INC. | DUOPA (Drug) | Food and Beverage | In-kind items and services | $107.33 | General |
| Category: NEUROSCIENCE | ||||||
| 08/22/2024 | Octapharma USA, Inc. | PANZYGA (Biological) | Food and Beverage | In-kind items and services | $13.75 | General |
| Category: IMMUNOLOGY | ||||||
| 08/16/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $18.79 | General |
| Category: Central Nervous System | ||||||
| 08/14/2024 | Takeda Pharmaceuticals U.S.A., Inc. | HYQVIA (Biological) | Food and Beverage | In-kind items and services | $24.68 | General |
| Category: IMMUNOLOGY | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| ACP-103-063 | ACADIA Pharmaceuticals Inc | $1,823 | 17 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 418 | 744 | $149,155 | $52,611 |
| 2022 | 12 | 454 | 753 | $151,348 | $54,138 |
| 2021 | 12 | 507 | 820 | $159,331 | $54,466 |
| 2020 | 13 | 504 | 747 | $147,255 | $45,422 |
Total Patients
1,883
Total Services
3,064
Medicare Billing
$206,637
Procedure Codes
48
All Medicare Procedures & Services
48 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 160 | 268 | $65,905 | $27,736 | 42.1% |
| 64616 | Injection of chemical for paralysis of nerve muscles on side of neck excluding voice box | Facility | 2023 | 24 | 64 | $14,630 | $6,701 | 45.8% |
| 64612 | Injection of chemical for paralysis of nerve muscles on side of face | Facility | 2023 | 14 | 33 | $17,458 | $3,880 | 22.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 26 | 26 | $9,568 | $3,329 | 34.8% |
| 64611 | Injection of chemical for paralysis of salivary glands on both sides of mouth | Facility | 2023 | 14 | 28 | $7,308 | $2,225 | 30.4% |
| 95983 | Electronic analysis of implanted brain, spinal cord, or peripheral neurostimulator generator with brain stimulator programming, first 15 minutes with qualified health professional | Facility | 2023 | 35 | 57 | $7,182 | $2,066 | 28.8% |
| 95984 | Electronic analysis of implanted brain, spinal cord, or peripheral neurostimulator generator with brain stimulator programming, each additional 15 minutes with qualified health professional | Facility | 2023 | 24 | 62 | $6,820 | $2,047 | 30.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 25 | 27 | $4,644 | $1,666 | 35.9% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Facility | 2023 | 41 | 60 | $4,260 | $1,353 | 31.8% |
| 95874 | Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle | Facility | 2023 | 35 | 87 | $6,612 | $1,176 | 17.8% |
| 95970 | Electronic analysis of implanted brain, spinal cord, or peripheral neurostimulator generator | Facility | 2023 | 20 | 32 | $4,768 | $433.50 | 9.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 138 | 224 | $55,125 | $23,880 | 43.3% |
| 64616 | Injection of chemical for paralysis of nerve muscles on side of neck excluding voice box | Facility | 2022 | 25 | 61 | $14,212 | $6,423 | 45.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 40 | 40 | $14,720 | $5,643 | 38.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 58 | 67 | $11,524 | $4,826 | 41.9% |
| 64612 | Injection of chemical for paralysis of nerve muscles on side of face | Facility | 2022 | 18 | 36 | $19,488 | $4,078 | 20.9% |
| 95984 | Electronic analysis of implanted brain, spinal cord, or peripheral neurostimulator generator with brain stimulator programming, each additional 15 minutes with qualified health professional | Facility | 2022 | 16 | 69 | $7,590 | $2,330 | 30.7% |
| 95983 | Electronic analysis of implanted brain, spinal cord, or peripheral neurostimulator generator with brain stimulator programming, first 15 minutes with qualified health professional | Facility | 2022 | 32 | 52 | $6,552 | $1,995 | 30.4% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 12 | 17 | $3,944 | $1,348 | 34.2% |
| 95874 | Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle | Facility | 2022 | 38 | 82 | $6,232 | $1,200 | 19.3% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Facility | 2022 | 27 | 37 | $2,627 | $915.14 | 34.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 18 | 21 | $2,331 | $838.49 | 36.0% |
| 95970 | Electronic analysis of implanted brain, spinal cord, or peripheral neurostimulator generator | Facility | 2022 | 32 | 47 | $7,003 | $660.60 | 9.4% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 128 | 204 | $49,980 | $21,511 | 43.0% |
| 64616 | Injection of chemical for destruction of nerve muscles on one side of neck excluding voice box accessed through the skin | Facility | 2021 | 31 | 71 | $17,138 | $7,277 | 42.5% |
About Julie Kurek
Julie Kurek is a Neurology healthcare provider based in Augusta, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/29/2010. The National Provider Identifier (NPI) number assigned to this provider is 1306163324.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Julie Kurek has received a total of $27,870 in payments from pharmaceutical and medical device companies, with $1,660 received in 2024. These payments were reported across 615 transactions from 58 companies. The most common payment nature is "Food and Beverage" ($12,595).
As a Medicare-enrolled provider, Kurek has provided services to 1,883 Medicare beneficiaries, totaling 3,064 services with total Medicare billing of $206,637. Data is available for 4 years (2020–2023), covering 48 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Augusta, GA
- Active Since 04/29/2010
- Last Updated 09/30/2015
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1306163324
Products in Payments
- APOKYN (Drug) $7,561
- ACTIVA (Device) $2,578
- NUPLAZID (Drug) $2,373
- Ongentys (Drug) $1,726
- DBS IPGs (Device) $1,230
- BOTOX (Biological) $1,063
- GENERAL DBS (Device) $1,023
- AUSTEDO (Drug) $743.58
- DUOPA (Drug) $641.19
- Infinity DBS Pulse Generators (Device) $621.18
- INGREZZA (Drug) $501.57
- Fycompa (Drug) $463.63
- RYTARY (Drug) $315.29
- NORTHERA (Drug) $311.57
- BOTOX THERAPEUTIC (Biological) $305.78
- GOCOVRI (Drug) $270.71
- Austedo XR (Drug) $254.77
- APTIOM (Drug) $254.49
- Xeomin (Biological) $252.90
- Neuromodulation Dspsbls and Accs (Device) $250.92
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Augusta
John Morgan, Md, MD
Neurology — Payments: $745,663
Neurology $745,663
Alexis Shaefer, M.d, M.D
Neurology — Payments: $251,468
Neurology $251,468
Dr. John Henson, Md, MD
Neurology — Payments: $71,522
Neurology $71,522
Anthony Murro, Md, MD
Neurology — Payments: $66,836
Neurology $66,836
Dr. Colin Mcleod, M.d, M.D
Neurology — Payments: $44,607
Neurology $44,607
Dr. Bryan Ho, M.d, M.D
Neurology — Payments: $29,785
Neurology $29,785